Health05:46 · Aug 18

Israel Faces Severe Shortage of Pulmonologists Amid Growing Respiratory Disease Burden

WallaCenter
Translated & summarized from Walla by baba
The story · English

Israeli singer Yehuda Poliker recently revealed his struggle with pulmonary fibrosis, a lung disease causing tissue scarring and breathing difficulties, bringing public attention to a broader healthcare issue: a critical shortage of pulmonologists in Israel. According to Professor Zvi Friedland, chairman of the Israeli Pulmonary Medicine Association, there are currently about 170 adult pulmonology specialists nationwide, with fewer than 200 including trainees. Despite advances in respiratory medicine, such as biological treatments and improved diagnostic methods, the healthcare system lacks sufficient specialists to meet rising patient demand.

The number of pulmonology trainees has increased to around 40 this year, up from 15-20 in previous years, reflecting the field's growing therapeutic options and procedures. However, a significant bottleneck exists as there are insufficient job positions for these specialists upon completing their lengthy training, which includes four years of internal medicine followed by two and a half years of pulmonology. Patients often face wait times exceeding three months for community pulmonology appointments, delaying care for symptoms like cough and sputum.

The shortage is especially acute in southern Israel, where community pulmonology services are most limited. The aging population and increased detection of lung diseases, partly due to expanded low-dose CT screening for lung cancer, are expected to further increase demand. While early detection improves outcomes, it also adds pressure on specialists to interpret results and manage follow-up care.

Additional challenges include limited access to pulmonary rehabilitation, a treatment proven to enhance chronic patients' quality of life but hindered by inadequate funding and reimbursement policies. Professor Friedland also criticized the Israeli government's failure to effectively combat smoking, the leading risk factor for lung diseases, noting high smoking rates among adults and youth, including increased use of e-cigarettes.

Despite these difficulties, Friedland emphasized that Israeli pulmonary medicine is advancing with new therapies and procedures, but the shortage of specialists restricts the healthcare system's ability to fully utilize these innovations. He called for doubling pulmonology positions to better serve patients and address regional disparities, particularly in peripheral areas.

Read the original at Walla
Open the live terminal